16 May 2016
Mumbai
Reporter: Tammy Facey

India grants Gilead Sciences patent for Sovaldi


Gilead Sciences has had its patent application for hepatitis C treatment Sovaldi (sofosbuvir) accepted in India.

The Indian Intellectual Property Office (IIPO) granted Gilead’s application for the patent on 7 May, after rejecting its initial application in January last year.

The IIPO initially rejected the application on the ground of evergreening, ruling that the mere discovery of a new form of a known substance, which does not result in the enhancement of the known efficacy of the substance, is not eligible for patent protection.

Gilead appealed against the decision and on 7 May the IIPO approved the formulation, describing the drug compound as novel and inventive.

Gilead faced opposition from the Initiative for Medicines, Access and Knowledge (I-MAK) over access to the drug in certain countries.

I-MAK claimed the treatment was too expensive. The recommended 12-week course of treatments costs $84,000 in the US, or $1,000 per pill.

But in India, Gilead is engaged in voluntary licensing programmes with 11 generic manufacturers.

As of 26 April, the cost of Sovaldi was $384 per bottle, or around $14 per pill, in India, according to the Asia Pacific Network of People Living with HIV.

A spokesperson for Gilead commented: “We welcome news that the [IIPO] of New Delhi has granted our patent application.”

The spokesperson added: “[Our current] licensing programme enables the manufacture and distribution of high-quality, low-cost versions of the company’s medicines for HIV, hepatitis B and hepatitis C.”

More Asia news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
China world’s top patent filer in 2016
07 December 2017 | Geneva | Reporter: Barney Dixon
China has emerged as the top patent filer in the world, accounting for nearly all of the 8 percent growth in patent applications in 2016
China to bolster IP rights protection mechanisms
27 November 2017 | Beijing | Reporter: Barney Dixon
China will ramp up its intellectual property rights protection mechanisms to promote economic development, according to the country’s premier Li Keqiang
EPO and SIPO strengthen bonds
23 November 2017 | Zhengzhou | Reporter: Barney Dixon
The European Patent Office and China’s State Intellectual Property Office have renewed their strategic partnership
MediaTek partners with Anaqua
20 November 2017 | Boston | Reporter: Barney Dixon
Taiwanese semiconductor company MediaTek has selected Anaqua to manage its intellectual property activities, including its inventions and patents
Brazil and China sign PPH agreement
17 November 2017 | Beijing | Reporter: Barney Dixon
The State Intellectual Property Office of China has signed a patent prosecution highway agreement with the Brazilian National Institution of Intellectual Property
Novagraaf and Mitsui partner to expand Japanese presence
30 October 2017 | Tokyo | Reporter: Barney Dixon
Intellectual property consultancy Novagraaf has partnered with Mitsui to further its reach in Japanese markets
Qualcomm hit with $775 million fine in Taiwan
13 October 2017 | Taipei | Reporter: Barney Dixon
Qualcomm has been hit with a $775 million fine, after the Taiwan Fair Trade Commission found that the chipmaker had abused its position in the baseband chip market